|
Accreditation |
0.75 AMA PRA Category 1 Credit(s)™.
The Cleveland Clinic Foundation Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Cleveland Clinic Foundation Center for Continuing Education designates this educational activity for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
This activity may be submitted for American Osteopathic Association Continuing Medical Education credit in Category 2. |
Target Audience |
This activity will be directed to rheumatologists, gastroenterologists, dermatologists, pulmonologists, nurse practitioners, physician assistants, and other health care professionals interested in or using biologic therapeutics in autoimmune and inflammatory disorders. |
Description |
This activity was presented at the Cleveland Clinic Richard J. Fasenmyer Center of Clinical Immunology Biologic Therapies for Autoimmune and Inflammatory Disease States Summit. The reviewed advances in biologic therapies for autoimmune diseases. |
Objectives |
At the conclusion of this activity, the participant will be able to:
- Recognize current state of understanding of the clinical presentation, classification and pathophysiology of psoriatic arthritis.
- Review current management options for psoriatic arthritis.
- Explain developments in therapies for psoriatic arthritis.
- Discuss emerging health-related quality of life concepts in psoriasis and psoriatic arthritis.
|
Activity Director |
Leonard H. Calabrese, DO
Professor of Medicine
Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
Vice Chairman
Department of Rheumatic and Immunologic Diseases
R.J. Fasenmyer Chair of Clinical Immunology |
Faculty |
Elaine Husni, MD, MPH Philip Mease, MD Abrar Qureshi, MD, MPH |
Faculty Disclosure |
In accordance with the Standards for Commercial Support issued by the Accreditation Council for Continuing Medical Education (ACCME), The Cleveland Clinic Foundation Center for Continuing Education requires resolution of all faculty conflicts of interest to ensure CME activities are free of commercial bias.
The following faculty have indicated that they may have a relationship, which in the context of their presentation(s), could be perceived as a potential conflict of interest:
| Leonard Calabrese, DO |
|
Consulting, Teaching and Speaking |
Genentech |
|
Teaching and Speaking |
Abbott; Amgen; Wyeth |
| |
Philip Mease, MD |
|
Consulting, Teaching and Speaking
and Independent Contractor |
Abbott; Biogen IDEC; Centocor; Genentech and Wyeth
|
|
Consulting, Teaching and Speaking Independent Contractor and Stockholder
|
Amgen
|
| |
Consulting, Teaching and Speaking |
Schering-Plough |
| |
Abrar Qureshi, MD, MPH |
| |
Consulting, Teaching and Speaking |
Abbott; Amgen and Genentech |
| |
Consulting |
Centocor |
The following faculty member has indicated she has no relationship which, in the context of her presentation, could be perceived as a potential conflict of interest:
Elaine Husni, MD, MPH |
| Estimated Time of Completion |
45 minutes. |
The Cleveland Clinic Foundation Center for Continuing Education acknowledges educational grants for partial support of this activity from:
 |
 |
 |
| Genentech and Biogen Idec. |
 |
 |
Gold Level

This CME activity was produced by The Cleveland Clinic Foundation Center for Continuing Education and UNITECH Communications®.
Contact Information | Privacy Policy | Disclaimer
Copyright © 2008 The Cleveland Clinic Foundation. All Rights Reserved. |